Cardiac arrhythmia is one of the most prevalent cardiovascular diseases worldwide, which
can occur alone or be triggered by other diseases, and it can be fatal in severe cases …

Type 2 diabetes is associated with a higher risk of cardiac arrhythmias, especially in
presence of cardiovascular disease and/or heart failure. Even if atrial fibrillation/flutter …

Background DNA methylation (DNAm) may contribute to processes that underlie
associations between air pollution and poor health. Therefore, our objective was to evaluate …

The co-formulation of glyburide (Gly) and vanillic acid (VA) as such in the form of
nanomedicine has never been explored to treat metabolic diseases including type 2 …

Background Commonly prescribed diabetic medications such as metformin and sulfonylurea
may be associated with different arrhythmogenic risks. This study compared the risk of …

BACKGROUND: Hypoxia-ischemia predisposes to atrial arrhythmia. Atrial ATP-sensitive
potassium channel (KATP) modulation during hypoxia has not been explored. We …

Aims To gain insights on the cardiovascular effects of metformin and sulphonylurea, the
present study compares the rates of incident atrial fibrillation, stroke, cardiovascular mortality …

Previous studies have suggested an association between sulfonylureas and an increased
risk of cardiovascular death among patients with type 2 diabetes. A potential mechanism …

Diabetes and cancer are common diseases and are frequently diagnosed in the same
individual. These patients need to take antidiabetic drugs while receiving antitumor drugs …

OBJECTIVE To examine the association between individual antidiabetic sulfonylureas and
outpatient-originating sudden cardiac arrest and ventricular arrhythmia (SCA/VA) …